Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Precancerous Conditions × Bortezomib × Clear all

Sponsor

Conditions

Multiple Myeloma 131 Lymphoma, Mantle-Cell 27 Neoplasms, Plasma Cell 19 Lymphoma, Follicular 19 Lymphoma 19 Lymphoma, Non-Hodgkin 18 Recurrence 15 Leukemia, Myeloid, Acute 12 Waldenstrom Macroglobulinemia 11 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Large B-Cell, Diffuse 10 Immunoglobulin Light-chain Amyloidosis 10 Lymphoma, B-Cell, Marginal Zone 8 Leukemia, Lymphocytic, Chronic, B-Cell 8 Neoplasms 7 Leukemia 6 Carcinoma, Non-Small-Cell Lung 6 Myelodysplastic Syndromes 5 Hematologic Neoplasms 5 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, B-Cell 4 Hematologic Diseases 4 Congenital Abnormalities 4 Brain Neoplasms 4 Amyloidosis 4 Paraproteinemias 3 Leukemia, Myelomonocytic, Acute 3 Leukemia, Monocytic, Acute 3 Leukemia, Erythroblastic, Acute 3 Leukemia, B-Cell 3

Interventions

Whole-Body Irradiation 4 Sulindac 4 Peripheral Blood Stem Cell Transplantation 4 Methotrexate 4 fludarabine phosphate 3 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3 Cetuximab 3 Tacrolimus 2 Sirolimus 2 Selenium 2 Radiotherapy, Intensity-Modulated 2 Polymerase Chain Reaction 2 Mycophenolic Acid 2 Melphalan 2 Gene Expression Profiling 2 Etoposide 2 Darbepoetin alfa 2 Cyclosporine 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 Biopsy 2 Aspirin 2 Aminolevulinic Acid 2 Albumin-Bound Paclitaxel 2 vandetanib 1 polyphenon E 1 perillyl alcohol 1 peginterferon alfa-2b 1 human papillomavirus vaccine, L1 type 16, 18 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡